| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 07/31/2003 | WO2003061601A2 Aminophospholipid transporter atpase |
| 07/31/2003 | WO2003061583A2 Digenic mutations associated with severe insulin resistance and type 2 diabetes and their use in the diagnosis and treatment of diabetes |
| 07/31/2003 | WO2003061570A2 Engineered binding proteins |
| 07/31/2003 | WO2003048308A3 Thermus brockianus nucleic acid polymerases |
| 07/31/2003 | WO2003040381A3 Enzymatic process for the manufacture of l-ascorbic acid and d-erythorbic acid |
| 07/31/2003 | WO2003037253A3 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/31/2003 | WO2003031571A3 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 07/31/2003 | WO2003016338A9 Crystal structure of the btk kinase domain |
| 07/31/2003 | WO2003008603A3 Process for the preparation of l-amino acids using strains of the enterobacteri acea family which contain an attenuated aspa gene |
| 07/31/2003 | WO2003008602A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene |
| 07/31/2003 | WO2003004670A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced pts-g expression |
| 07/31/2003 | WO2003004664A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced fba expression |
| 07/31/2003 | WO2003004607A3 Aggrecanase molecules |
| 07/31/2003 | WO2003002736A3 A walk-through technique for in vitro recombination of polynucleotide sequences |
| 07/31/2003 | WO2002103032A3 Catalases, nucleic acids encoding them and methods for making and using them |
| 07/31/2003 | WO2002103023A3 Method for producing c9-aldehydes, c9-alcohols by means of divinyl ether synthase |
| 07/31/2003 | WO2002090571A3 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 07/31/2003 | WO2002090377A3 Peptides that bind to dna and inhibit dna replication, and methods of use |
| 07/31/2003 | WO2002088363A3 Regulation of novel human prolyl 4-hydroxylases |
| 07/31/2003 | WO2002083931A3 Method for fixing biomolecules onto chemically inert surfaces |
| 07/31/2003 | WO2002081667A3 Ligases |
| 07/31/2003 | WO2002068464A3 Fusion protein for blocking the hiv nef protein |
| 07/31/2003 | WO2002038742A3 Dipeptidylpeptidases and methods of use |
| 07/31/2003 | WO2002033041A3 Production of bovine lysozyme by plant viral vectors |
| 07/31/2003 | WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 07/31/2003 | WO2002024747A3 Polymorphisms in human genes of cardiovascular regulators and their use in diagnostic and therapeutic applications |
| 07/31/2003 | WO2002020847A3 Gene and sequence variation associated with lipid disorder |
| 07/31/2003 | WO2002018548A3 Tyrosine hydroxylase 5' control elements and uses thereof |
| 07/31/2003 | WO2002004489A3 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 07/31/2003 | US20030145354 Genetic engineered DNA comprising regulatory sequences of plant cell promoters linked DNA sequences that code for proteins or fragments that suppress endogenous gene expression transferase enzymes; agriculture |
| 07/31/2003 | US20030145353 Polynucleotide comprising chimera genes linked to regulatory sequences that code for glycogenin, used for transforming cells and regenerating plants; genetic engineering |
| 07/31/2003 | US20030145352 Nucleic acid molecules from rice and their use for the production of modified starch |
| 07/31/2003 | US20030145351 Isolation of DNA sequences that code for synthase enzymes, used for screening herbicide, fungicide, bactericides and/or pesticides; genetic engineering |
| 07/31/2003 | US20030145350 Method for increasing the content of fatty acids in plants and micro-organisms |
| 07/31/2003 | US20030145349 Plant transcription coactivators with histone acetyl transferase activity |
| 07/31/2003 | US20030145348 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target |
| 07/31/2003 | US20030145347 Grain processing method and transgenic plants useful therein |
| 07/31/2003 | US20030144497 Novel human transferase proteins and polynucleotides encoding the same |
| 07/31/2003 | US20030144496 Isolated polypeptides; genetic engineering |
| 07/31/2003 | US20030144495 Drosophila recombination-associated protein and methods for use |
| 07/31/2003 | US20030144493 Human serine protease |
| 07/31/2003 | US20030144491 Methods and materials relating to cadherin-like polypeptides and polynucleotides |
| 07/31/2003 | US20030144228 PON3 and uses thereof |
| 07/31/2003 | US20030144227 Pharmaceutical composition comprising Nit2 for use in inhibiting tumor cell growth |
| 07/31/2003 | US20030144226 Drug screening for an antiviral agent, viricides; genetic engineering |
| 07/31/2003 | US20030144205 Polynucleotide sequence encoding a polypeptide comprising an amino acid sequence that modulates protein degradation during gametogenesis and early development |
| 07/31/2003 | US20030144204 Expression vector with an inducible chimeric protein, wherein said protein comprises a mutant Akt polypeptide fused to a ligand binding domain |
| 07/31/2003 | US20030144180 Contains as active ingredient a therapeutically effective amount of agent for either enhancing protein kinase c production and/or activation |
| 07/31/2003 | US20030144165 For use in detergents and in baking |
| 07/31/2003 | US20030143740 Integrating nucleic acid into the genome of mammalian cells by forming an integrator complex between a nucleic acid containing a transposon and a transposase specific for the transposon |
| 07/31/2003 | US20030143715 Glutaryl cephalosporin amidase from pseudomonas diminuta BS-203 |
| 07/31/2003 | US20030143714 Crystal structure of a mutant of cathepsin S enzyme |
| 07/31/2003 | US20030143713 Novel glycosidase inhibitors and their pharmacological uses, in particular for treating diabetes |
| 07/31/2003 | US20030143712 Nucleic acid; use identifying the enzyme inhibitors which are used as antitumor agents; detection of cells expressing the enzyme |
| 07/31/2003 | US20030143711 Hydrolyses organophosphate insecticides including malathion; bioremediation |
| 07/31/2003 | US20030143710 Protein corresponding to recombinant fungal epoxide hydrolase; use making enantiomerically pure diols and/or epoxides |
| 07/31/2003 | US20030143703 Recombinant microorganism expressing polyhydroxyalkanoate biosynthesis enzyme and intracellular PHA depolymerase |
| 07/31/2003 | US20030143700 Specific, asymmetric reduction of 3-quinuclidinone using tropinone reductase-I in the presence of a reduced coenzyme to produce (R)-3-quinuclidinol; high optical purity |
| 07/31/2003 | US20030143692 Methods and compositions for modulating integrin-mediated cell-cell interactions |
| 07/31/2003 | US20030143690 Peptides and proteins that effect protein phosphorylation; genetic engineered DNA; useful for therapy and diagnosis |
| 07/31/2003 | US20030143688 Human skeletal muscle-specific ubiquitin-conjugating enzyme |
| 07/31/2003 | US20030143686 Transferases |
| 07/31/2003 | US20030143677 Activated rec-D-hydantoinases |
| 07/31/2003 | US20030143675 Novel 38594, 57312, 53659, 57250, 63760, 49938, 32146, 57259, 67118, 67067, 62092, 8099, 46455, 54414, 53763, 67076, 67102, 44181, 67084FL, 67084ALT, FBH58295FL, 57255, and 57255alt molecules and uses therefor |
| 07/31/2003 | US20030143674 Polypeptides fused to heterologous polypeptide sequences, and an antibodies which bind to the above polypeptides |
| 07/31/2003 | US20030143669 Contacting a mammalian cell culture expressing a lysosomal hydrolase with a mutagenic agent; culturing culture in presence of pseudomonas exotoxin A to select for cell resistant to the pseudomonas, isolating lysosomal hydrolase |
| 07/31/2003 | US20030143660 Genes have been isolated from Rhodococcus and Deinococcus which encode a specific lycopene beta -cyclase capable of converting acyclic carotenoids with atleast one psi-end group to corresponding asymetric caratenoid |
| 07/31/2003 | US20030143657 For identification of fungicides which affect biosynthesis of l-leucine; drug screening |
| 07/31/2003 | US20030143656 Drug screening compounds which inhibit rate of phosphorylation by kinase having hydrophobic pocket domain; surface plasmon resonance; fusion proteins; anticancer-/ antidiabetic agents |
| 07/31/2003 | US20030143648 Enzyme activity profiles |
| 07/31/2003 | US20030143632 Fusion proteins; tango genes; drug screening; competitive binding assay |
| 07/31/2003 | US20030143624 Trans-prenyl-protein transferases; animal models; drug screening |
| 07/31/2003 | US20030143620 Carbohydrate ligands specific for MHC molecules |
| 07/31/2003 | US20030143618 PCR amplification of each part of the two parts of DNA molecule by means of two primer sets that build in a recombiantion site at the outer end of each PCR product, ligation of PCR product, recombiantion cloning of the PCR |
| 07/31/2003 | US20030143617 ATP synthase subunits |
| 07/31/2003 | US20030143589 Drug metabolizing enzymes |
| 07/31/2003 | US20030143588 Phosphodiesterases |
| 07/31/2003 | US20030143577 High fidelity DNA polymerase compositions and uses therefor |
| 07/31/2003 | US20030143567 An expression vector containing a promoter operably linked to a nucleic acid that encodes a prokaryotic enzyme having both epimerase/ reductase activity catalyzes conversion of GDP-4-keto-6-deoxymannose to GDP-fucose |
| 07/31/2003 | US20030143528 Vector for analayzing replication mechanism of rna virus and use thereof |
| 07/31/2003 | US20030143522 Screening and use of agents which block or activate intein splicing utilizing natural or homologous exteins |
| 07/31/2003 | US20030143244 For preparation of D-amino acids starting from 5'-substituted hydantoins |
| 07/31/2003 | US20030143240 Prostase protein vaccine comprising derivatised thiol residues and methods for producing said antigen |
| 07/31/2003 | US20030143228 Human telomerase reverse transcriptase as a class-II restricted tumor-associated antigen |
| 07/31/2003 | US20030143219 Therapy and prophylaxis of neoplastic disease, in a mammal |
| 07/31/2003 | US20030143216 For therapy of fungal infections; for detecting chitin, binding chitin |
| 07/31/2003 | US20030143209 For gene therapy of cancers or cardiovascular conditions |
| 07/31/2003 | US20030143208 For therapy of neurodegenerative disorders associated with oxidative damage and subsequent neuronal cell loss, including, but not limited to, Parkinson's disease and head trauma |
| 07/31/2003 | US20030143206 Increasing the level of at least one isoform of the enzyme nitric oxide synthase in the cells of the ano-rectal region for therapy of anal disease |
| 07/31/2003 | US20030143198 Method for preparing a physiologically active il-18 polypeptide |
| 07/31/2003 | CA2829859A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2732012A1 Genetic sequences having methyltransferase activity and uses therefor |
| 07/31/2003 | CA2474033A1 Fermentation of pentose sugars |
| 07/31/2003 | CA2473716A1 Alanine 2,3- aminomutase |
| 07/31/2003 | CA2473032A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 07/31/2003 | CA2472775A1 Synthetic peptides and uses thereof for the prevention and therapy of cancer invasion and metastasis |
| 07/31/2003 | CA2472729A1 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression |
| 07/31/2003 | CA2472725A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2472723A1 Multiply-substituted protease variants |
| 07/31/2003 | CA2454358A1 Multimeric proteins and methods of making and using same |